These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21944982)

  • 21. Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.
    Dimopoulos MA; Zervas C; Zomas A; Hamilos G; Gika D; Efstathiou E; Panayiotidis P; Vervessou E; Anagnostopoulos N; Christakis J
    Clin Lymphoma; 2002 Dec; 3(3):163-6. PubMed ID: 12521393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy.
    Baird SM; Kenealy MK; Hoy R
    Leuk Lymphoma; 2015; 56(11):3233-5. PubMed ID: 25837422
    [No Abstract]   [Full Text] [Related]  

  • 23. Fludarabine in Waldenstrom's macroglobulinemia.
    Souchet-Compain L; Nguyen S; Choquet S; Leblond V
    Expert Rev Hematol; 2013 Jun; 6(3):229-37. PubMed ID: 23782076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of rituximab on a patient with Waldenström's macroglobulinaemia with deletion 13q14.
    Mori A; Tamaru J; Kondo H
    Eur J Haematol; 2002; 69(5-6):321-3. PubMed ID: 12460239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
    Zinzani PL; Tani M; Alinari L; Stefoni V; Baccarani M
    Leuk Res; 2003 May; 27(5):465-6. PubMed ID: 12620298
    [No Abstract]   [Full Text] [Related]  

  • 26. [Waldenström's hyperglobulinemic purpura, Waldenström's macroglobulinemia].
    Fischer M
    Thromb Diath Haemorrh Suppl; 1968; 30():155-6. PubMed ID: 5005718
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunoglobulin M 'Flare' after rituximab-associated acute tubular necrosis in Waldenström's macroglobulinemia.
    Izzedine H; Bourry E; Amrouche L; Brocheriou I; Uzunov M; Capron F; Leblond V; Deray G
    Int J Hematol; 2009 Mar; 89(2):218-222. PubMed ID: 19156501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended rituximab therapy in Waldenström's macroglobulinemia.
    Treon SP; Emmanouilides C; Kimby E; Kelliher A; Preffer F; Branagan AR; Anderson KC; Frankel SR;
    Ann Oncol; 2005 Jan; 16(1):132-8. PubMed ID: 15598950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Waldenström's macroglobulinemia--the experts opinion about new therapeutic possibilities and response criteria].
    Jurczyszyn A; Skotnicki AB
    Pol Arch Med Wewn; 2004 Sep; 112(3):1113-21. PubMed ID: 15727094
    [No Abstract]   [Full Text] [Related]  

  • 31. Resolution of Waldenström's macroglubulinemia related isolated neutropenia by immunochemotherapy.
    van Gelder M; van Marion A; Goossens V; Bommer M; Leblond V
    Am J Hematol; 2011 Apr; 86(4):380-2. PubMed ID: 21442645
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
    Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
    Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].
    Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A
    Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé J; Montoto S; Rosiñol L; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab-based treatments in Waldenström's macroglobulinemia.
    Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.
    Le Garff-Tavernier M; Herbi L; de Romeuf C; Azar N; Roos-Weil D; Bonnemye P; Urbain R; Leblond V; Merle-Beral H; Vieillard V
    Haematologica; 2015 Apr; 100(4):e147-51. PubMed ID: 25552707
    [No Abstract]   [Full Text] [Related]  

  • 38. Nodular amyloidosis of all four eyelids: first presenting symptom of Waldenström macroglobulinaemia.
    Jacoby S; Toft PB; Prause JU; Philip P; Heegaard S
    Acta Ophthalmol; 2014 Jun; 92(4):392-3. PubMed ID: 23601930
    [No Abstract]   [Full Text] [Related]  

  • 39. The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens.
    Dimopoulos MA; Kastritis E; Delimpassi S; Zomas A; Kyrtsonis MC; Zervas K
    Haematologica; 2008 Sep; 93(9):1420-2. PubMed ID: 18641029
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictive factors for response to rituximab in Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Anagnostopoulos A; Zervas C; Kyrtsonis MC; Zomas A; Bourantas C; Anagnostopoulos N; Pangalis G
    Clin Lymphoma; 2005 Mar; 5(4):270-2. PubMed ID: 15794863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.